CoChat
Sign Up
Cited by 56

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Extracellular Fluid Volume Expansion Uncovers a Natriuretic Action of GLP-1: A Functional GLP-1–Renal Axis in Man

Asmar, Ali, Cramon, Per K, Simonsen, Lene, Asmar, Meena, Sorensen, Charlotte M, Madsbad, Sten, Moro, Cedric, Hartmann, Bolette, Jensen, Boye L, Holst, Jens J, Bülow, Jens·2019·The Journal of Clinical Endocrinology & Metabolism
DOI 10.1210/jc.2019-00004
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2019-00004

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 30

  1. Holst, 2007, The physiology of glucagon-like peptide 1, Physiol Rev, 87, 1409, 10.1152/physrev.00034.2006 · DOI · Paper page
  2. Korner, 2007, GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting, 736
  3. Pyke, 2013, The glucagon-like peptide-1 receptor--or not, Endocrinology, 154, 4, 10.1210/en.2012-2124 · DOI · Paper page
  4. Muskiet, 2017, GLP-1 and the kidney: from physiology to pharmacology and outcomes in diabetes, Nat Rev Nephrol, 13, 605, 10.1038/nrneph.2017.123 · DOI · Paper page
  5. Skov, 2014, Effects of GLP-1 in the kidney, Rev Endocr Metab Disord, 15, 197, 10.1007/s11154-014-9287-7 · DOI
  6. Gutzwiller, 2004, Glucagon-like peptide 1 induces natriuresis in healthy subjects and in insulin-resistant obese men, J Clin Endocrinol Metab, 89, 3055, 10.1210/jc.2003-031403 · DOI · Paper page
  7. Skov, 2014, Glucagon-like peptide-1: effect on pro-atrial natriuretic peptide in healthy males, Endocr Connect, 3, 11, 10.1530/EC-13-0087 · DOI
  8. Asmar, 2015, Renal extraction and acute effects of glucagon-like peptide-1 on central and renal hemodynamics in healthy men, Am J Physiol Endocrinol Metab, 308, E641, 10.1152/ajpendo.00429.2014 · DOI
  9. Asmar, 2016, Glucagon-like peptide-1 does not have acute effects on central or renal hemodynamics in patients with type 2 diabetes without nephropathy, Am J Physiol Endocrinol Metab, 310, E744, 10.1152/ajpendo.00518.2015 · DOI
  10. Jose, 2016, Gastrorenal axis, Hypertension, 67, 1056, 10.1161/HYPERTENSIONAHA.115.06424 · DOI
  11. Jose, 2016, The importance of the gastrorenal axis in the control of body sodium homeostasis, Exp Physiol, 101, 465, 10.1113/EP085286 · DOI
  12. Michell, 2008, Regulation of renal function by the gastrointestinal tract: potential role of gut-derived peptides and hormones, Annu Rev Physiol, 70, 379, 10.1146/annurev.physiol.69.040705.141330 · DOI
  13. Yang, 2017, Gastrointestinal-renal axis: role in the regulation of blood pressure, J Am Heart Assoc, 6, e005536, 10.1161/JAHA.117.005536 · DOI
  14. Orskov, 1994, Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans, Diabetes, 43, 535, 10.2337/diab.43.4.535 · DOI
  15. Poulsen, 1974, An easy radioimmunological microassay of renin activity, concentration and substrate in human and animal plasma and tissues based on angiotensin I trapping by antibody, J Clin Endocrinol Metab, 39, 816, 10.1210/jcem-39-5-816 · DOI
  16. Bie, 2000, Determinants of the natriuresis after acute, slow sodium loading in conscious dogs, Am J Physiol Regul Integr Comp Physiol, 278, R1, 10.1152/ajpregu.2000.278.1.R1 · DOI
  17. Plamboeck, 2013, Characterisation of oral and i.v. glucose handling in truncally vagotomised subjects with pyloroplasty, Eur J Endocrinol, 169, 187, 10.1530/EJE-13-0264 · DOI
  18. Muskiet, 2016, Acute renal haemodynamic effects of glucagon-like peptide-1 receptor agonist exenatide in healthy overweight men, Diabetes Obes Metab, 18, 178, 10.1111/dom.12601 · DOI · Paper page
  19. Harris, 1985, Tubular transport responses to angiotensin, Am J Physiol, 248, F621
  20. Mendelsohn, 1983, Characteristics and regulation of angiotensin II receptors in pituitary, circumventricular organs and kidney, Clin Exp Hypertens A, 5, 1081
  21. Friis, 2013, Regulation of renin secretion by renal juxtaglomerular cells, Pflugers Arch, 465, 25, 10.1007/s00424-012-1126-7 · DOI
  22. Kobori, 2007, The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease, Pharmacol Rev, 59, 251, 10.1124/pr.59.3.3 · DOI
  23. Ellis, 2012, Evidence for a functional intracellular angiotensin system in the proximal tubule of the kidney, Am J Physiol Regul Integr Comp Physiol, 302, R494, 10.1152/ajpregu.00487.2011 · DOI
  24. Cervenka, 1998, Effects of acute AT1 receptor blockade by candesartan on arterial pressure and renal function in rats, Am J Physiol, 274, F940
  25. Bie, 2018, Natriuretic peptides and normal body fluid regulation, Compr Physiol, 8, 1211, 10.1002/cphy.c180002 · DOI
  26. Drucker, 2006, The biology of incretin hormones, Cell Metab, 3, 153, 10.1016/j.cmet.2006.01.004 · DOI · Paper page
  27. Lezoualc’h, 2016, Cyclic AMP sensor EPAC proteins and their role in cardiovascular function and disease, Circ Res, 118, 881, 10.1161/CIRCRESAHA.115.306529 · DOI
  28. Asmar, 2017, Glucagon-like peptide-1 elicits vasodilation in adipose tissue and skeletal muscle in healthy men, Physiol Rep, 5, e13073, 10.14814/phy2.13073 · DOI
  29. Moreno, 2002, Renal effects of glucagon-like peptide in rats, Eur J Pharmacol, 434, 163, 10.1016/S0014-2999(01)01542-4 · DOI
  30. Badzyńska, 2002, Differential effect of angiotensin II on blood circulation in the renal medulla and cortex of anaesthetised rats, J Physiol, 538, 159, 10.1113/jphysiol.2001.012921 · DOI

Cited by

Sorted by citations

Metadata

Authors
Asmar, A., Cramon, P. K., Simonsen, L., Asmar, M., Sorensen, C. M., Madsbad, S., Moro, C., Hartmann, B., Jensen, B. L., Holst, J. J., & Bülow, J.
Venue
The Journal of Clinical Endocrinology & Metabolism
Publisher
The Endocrine Society
Published
2019-03-05
Volume
104
Issue
7
Pages
2509-2519
ISSN
  • 0021-972X
  • 1945-7197
DOI
10.1210/jc.2019-00004
Cited by
56
References
8
Language
en

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review